Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immunoglobulin
Pharma
Kedrion wins FDA nod for immunodeficiency disorder treatment
Italian plasma specialist Kedrion has scored an FDA approval for Qivigy, a treatment for a adults with primary humoral immunodeficiency.
Kevin Dunleavy
Sep 29, 2025 11:39am
Grifols deflects private equity firm's potential takeover offer
Nov 20, 2024 10:13am
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
Dec 20, 2023 5:24pm
Novartis shows strong Fabhalta results in another blood disorder
Dec 11, 2023 11:20am
Novartis gains first FDA approval for touted blood disorder drug
Dec 6, 2023 11:02am
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
